COLOPLAST-B (CBHD.DE) Stock Fundamental Analysis
Europe - FRA:CBHD - DK0060448595 - Common Stock
82.76 EUR
+0.78 (+0.95%)
CBHD gets a fundamental rating of 5 out of 10. The analysis compared the fundamentals against 59 industry peers in the Health Care Equipment & Supplies industry. CBHD has an excellent profitability rating, but there are concerns on its financial health. CBHD is not valued too expensively and it also shows a decent growth rate.
1. Profitability
1.1 Basic Checks
In the past year CBHD was profitable.
In the past year CBHD had a positive cash flow from operations.
In the past 5 years CBHD has always been profitable.
CBHD had a positive operating cash flow in each of the past 5 years.
1.2 Ratios
With an excellent Return On Assets value of 8.51%, CBHD belongs to the best of the industry, outperforming 83.05% of the companies in the same industry.
CBHD has a better Return On Equity (24.78%) than 93.22% of its industry peers.
Looking at the Return On Invested Capital, with a value of 15.96%, CBHD belongs to the top of the industry, outperforming 94.92% of the companies in the same industry.
Measured over the past 3 years, the Average Return On Invested Capital for CBHD is significantly above the industry average of 8.86%.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 8.51% | ||
| ROE | 24.78% | ||
| ROIC | 15.96% |
ROA(3y)11%
ROA(5y)18.91%
ROE(3y)37.52%
ROE(5y)45.66%
ROIC(3y)16.81%
ROIC(5y)28.33%
1.3 Margins
With an excellent Profit Margin value of 14.62%, CBHD belongs to the best of the industry, outperforming 83.05% of the companies in the same industry.
In the last couple of years the Profit Margin of CBHD has declined.
The Operating Margin of CBHD (26.99%) is better than 91.53% of its industry peers.
CBHD's Operating Margin has declined in the last couple of years.
With a decent Gross Margin value of 67.55%, CBHD is doing good in the industry, outperforming 74.58% of the companies in the same industry.
CBHD's Gross Margin has been stable in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 26.99% | ||
| PM (TTM) | 14.62% | ||
| GM | 67.55% |
OM growth 3Y-6.25%
OM growth 5Y-2.74%
PM growth 3Y-9.04%
PM growth 5Y-2.84%
GM growth 3Y-0.46%
GM growth 5Y-0.05%
2. Health
2.1 Basic Checks
CBHD has a Return on Invested Capital (ROIC), which is well above the Cost of Capital (WACC), which means it is creating value.
The number of shares outstanding for CBHD has been increased compared to 1 year ago.
Compared to 5 years ago, CBHD has more shares outstanding
The debt/assets ratio for CBHD is higher compared to a year ago.
2.2 Solvency
CBHD has an Altman-Z score of 4.07. This indicates that CBHD is financially healthy and has little risk of bankruptcy at the moment.
CBHD's Altman-Z score of 4.07 is fine compared to the rest of the industry. CBHD outperforms 74.58% of its industry peers.
CBHD has a debt to FCF ratio of 4.89. This is a neutral value as CBHD would need 4.89 years to pay back of all of its debts.
Looking at the Debt to FCF ratio, with a value of 4.89, CBHD is in line with its industry, outperforming 59.32% of the companies in the same industry.
CBHD has a Debt/Equity ratio of 1.05. This is a high value indicating a heavy dependency on external financing.
The Debt to Equity ratio of CBHD (1.05) is worse than 81.36% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.05 | ||
| Debt/FCF | 4.89 | ||
| Altman-Z | 4.07 |
ROIC/WACC2.58
WACC6.18%
2.3 Liquidity
CBHD has a Current Ratio of 1.00. This is a normal value and indicates that CBHD is financially healthy and should not expect problems in meeting its short term obligations.
Looking at the Current ratio, with a value of 1.00, CBHD is doing worse than 77.97% of the companies in the same industry.
CBHD has a Quick Ratio of 1.00. This is a bad value and indicates that CBHD is not financially healthy enough and could expect problems in meeting its short term obligations.
CBHD has a worse Quick ratio (0.64) than 83.05% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1 | ||
| Quick Ratio | 0.64 |
3. Growth
3.1 Past
CBHD shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -13.94%.
The Earnings Per Share has been growing slightly by 2.72% on average over the past years.
Looking at the last year, CBHD shows a small growth in Revenue. The Revenue has grown by 5.95% in the last year.
CBHD shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 8.54% yearly.
EPS 1Y (TTM)-13.94%
EPS 3Y-0.25%
EPS 5Y2.72%
EPS Q2Q%-30.39%
Revenue 1Y (TTM)5.95%
Revenue growth 3Y11.64%
Revenue growth 5Y8.54%
Sales Q2Q%1.06%
3.2 Future
CBHD is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 11.39% yearly.
Based on estimates for the next years, CBHD will show a small growth in Revenue. The Revenue will grow by 7.24% on average per year.
EPS Next Y-2.2%
EPS Next 2Y9.28%
EPS Next 3Y10.1%
EPS Next 5Y11.39%
Revenue Next Year3.97%
Revenue Next 2Y5.1%
Revenue Next 3Y5.89%
Revenue Next 5Y7.24%
3.3 Evolution
When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
A Price/Earnings ratio of 32.45 indicates a quite expensive valuation of CBHD.
CBHD's Price/Earnings ratio is in line with the industry average.
When comparing the Price/Earnings ratio of CBHD to the average of the S&P500 Index (27.30), we can say CBHD is valued inline with the index average.
Based on the Price/Forward Earnings ratio of 23.03, the valuation of CBHD can be described as rather expensive.
Based on the Price/Forward Earnings ratio, CBHD is valued a bit cheaper than the industry average as 61.02% of the companies are valued more expensively.
The average S&P500 Price/Forward Earnings ratio is at 22.73. CBHD is around the same levels.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 32.45 | ||
| Fwd PE | 23.03 |
4.2 Price Multiples
The rest of the industry has a similar Enterprise Value to EBITDA ratio as CBHD.
Based on the Price/Free Cash Flow ratio, CBHD is valued a bit cheaper than the industry average as 72.88% of the companies are valued more expensively.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 26.24 | ||
| EV/EBITDA | 17.29 |
4.3 Compensation for Growth
The excellent profitability rating of CBHD may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)11.93
EPS Next 2Y9.28%
EPS Next 3Y10.1%
5. Dividend
5.1 Amount
With a Yearly Dividend Yield of 3.58%, CBHD has a reasonable but not impressive dividend return.
CBHD's Dividend Yield is rather good when compared to the industry average which is at 2.13. CBHD pays more dividend than 98.31% of the companies in the same industry.
CBHD's Dividend Yield is a higher than the S&P500 average which is at 2.41.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 3.58% |
5.2 History
The dividend of CBHD has a limited annual growth rate of 5.57%.
Dividend Growth(5Y)5.57%
Div Incr Years0
Div Non Decr Years0
5.3 Sustainability
121.67% of the earnings are spent on dividend by CBHD. This is not a sustainable payout ratio.
CBHD's earnings are growing more than its dividend. This makes the dividend growth sustainable.
DP121.67%
EPS Next 2Y9.28%
EPS Next 3Y10.1%
FRA:CBHD (9/12/2025, 7:00:00 PM)
82.76
+0.78 (+0.95%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)
Earnings (Next)
Inst Owners27.78%
Inst Owner ChangeN/A
Ins Owners29.79%
Ins Owner ChangeN/A
Market Cap17.40B
Analysts67.69
Price Target94.75 (14.49%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 3.58% |
Yearly Dividend2.81
Dividend Growth(5Y)5.57%
DP121.67%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-18.87%
Min EPS beat(2)-22.36%
Max EPS beat(2)-15.38%
EPS beat(4)0
Avg EPS beat(4)-13.35%
Min EPS beat(4)-22.36%
Max EPS beat(4)-0.34%
EPS beat(8)0
Avg EPS beat(8)-10.21%
EPS beat(12)0
Avg EPS beat(12)-8.91%
EPS beat(16)1
Avg EPS beat(16)-7.89%
Revenue beat(2)0
Avg Revenue beat(2)-1.84%
Min Revenue beat(2)-2.12%
Max Revenue beat(2)-1.56%
Revenue beat(4)0
Avg Revenue beat(4)-1.03%
Min Revenue beat(4)-2.12%
Max Revenue beat(4)-0.03%
Revenue beat(8)1
Avg Revenue beat(8)-1.52%
Revenue beat(12)1
Avg Revenue beat(12)-1.36%
Revenue beat(16)4
Avg Revenue beat(16)-0.78%
PT rev (1m)-5.51%
PT rev (3m)-8.17%
EPS NQ rev (1m)-2.01%
EPS NQ rev (3m)-4.97%
EPS NY rev (1m)-14.71%
EPS NY rev (3m)-14.71%
Revenue NQ rev (1m)-0.69%
Revenue NQ rev (3m)-5.72%
Revenue NY rev (1m)-0.56%
Revenue NY rev (3m)-1.62%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 32.45 | ||
| Fwd PE | 23.03 | ||
| P/S | 4.66 | ||
| P/FCF | 26.24 | ||
| P/OCF | 20.2 | ||
| P/B | 7.89 | ||
| P/tB | N/A | ||
| EV/EBITDA | 17.29 |
EPS(TTM)2.55
EY3.08%
EPS(NY)3.59
Fwd EY4.34%
FCF(TTM)3.15
FCFY3.81%
OCF(TTM)4.1
OCFY4.95%
SpS17.76
BVpS10.48
TBVpS-8.58
PEG (NY)N/A
PEG (5Y)11.93
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 8.51% | ||
| ROE | 24.78% | ||
| ROCE | 20.15% | ||
| ROIC | 15.96% | ||
| ROICexc | 16.27% | ||
| ROICexgc | 89.1% | ||
| OM | 26.99% | ||
| PM (TTM) | 14.62% | ||
| GM | 67.55% | ||
| FCFM | 17.76% |
ROA(3y)11%
ROA(5y)18.91%
ROE(3y)37.52%
ROE(5y)45.66%
ROIC(3y)16.81%
ROIC(5y)28.33%
ROICexc(3y)17.22%
ROICexc(5y)29.72%
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)21.23%
ROCE(5y)39.82%
ROICexcg growth 3Y7.74%
ROICexcg growth 5Y2.01%
ROICexc growth 3Y-30.17%
ROICexc growth 5Y-21.96%
OM growth 3Y-6.25%
OM growth 5Y-2.74%
PM growth 3Y-9.04%
PM growth 5Y-2.84%
GM growth 3Y-0.46%
GM growth 5Y-0.05%
F-Score6
Asset Turnover0.58
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.05 | ||
| Debt/FCF | 4.89 | ||
| Debt/EBITDA | 1.95 | ||
| Cap/Depr | 109.63% | ||
| Cap/Sales | 5.31% | ||
| Interest Coverage | 7.46 | ||
| Cash Conversion | 72.46% | ||
| Profit Quality | 121.42% | ||
| Current Ratio | 1 | ||
| Quick Ratio | 0.64 | ||
| Altman-Z | 4.07 |
F-Score6
WACC6.18%
ROIC/WACC2.58
Cap/Depr(3y)114.16%
Cap/Depr(5y)140.02%
Cap/Sales(3y)5.02%
Cap/Sales(5y)6.04%
Profit Quality(3y)58.21%
Profit Quality(5y)66.95%
High Growth Momentum
Growth
EPS 1Y (TTM)-13.94%
EPS 3Y-0.25%
EPS 5Y2.72%
EPS Q2Q%-30.39%
EPS Next Y-2.2%
EPS Next 2Y9.28%
EPS Next 3Y10.1%
EPS Next 5Y11.39%
Revenue 1Y (TTM)5.95%
Revenue growth 3Y11.64%
Revenue growth 5Y8.54%
Sales Q2Q%1.06%
Revenue Next Year3.97%
Revenue Next 2Y5.1%
Revenue Next 3Y5.89%
Revenue Next 5Y7.24%
EBIT growth 1Y4.5%
EBIT growth 3Y4.66%
EBIT growth 5Y5.57%
EBIT Next Year23.01%
EBIT Next 3Y14.31%
EBIT Next 5Y12.32%
FCF growth 1Y53.38%
FCF growth 3Y-24.77%
FCF growth 5Y-17.33%
OCF growth 1Y43.32%
OCF growth 3Y-19.49%
OCF growth 5Y-8.71%